These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Wedderburn LR; Rider LG Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):665-78. PubMed ID: 19853831 [TBL] [Abstract][Full Text] [Related]
6. Use of methotrexate in inflammatory myopathies. Fendler C; Braun J Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453 [TBL] [Abstract][Full Text] [Related]
7. The arthritis of inflammatory childhood myositis syndromes. Tse S; Lubelsky S; Gordon M; Al Mayouf SM; Babyn PS; Laxer RM; Silverman ED; Schneider R; Feldman BM J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524 [TBL] [Abstract][Full Text] [Related]
17. Update on the clinical management of juvenile dermatomyositis. Huber AM Expert Rev Clin Immunol; 2018 Dec; 14(12):1021-1028. PubMed ID: 30308133 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study. Okong'o LO; Esser M; Wilmshurst J; Scott C Pediatr Rheumatol Online J; 2016 Nov; 14(1):60. PubMed ID: 27835954 [TBL] [Abstract][Full Text] [Related]
19. [Juvenile dermatomyositis]. Martini A; Ravelli A; Aramini L; Ramenghi B Pediatr Med Chir; 1990; 12(6):587-91. PubMed ID: 2093879 [TBL] [Abstract][Full Text] [Related]